NCC Group

Tension 1 of 6

In FY2022, the group deployed £153m in investing outflows — equivalent to 48.6% of that year's revenue — with debt issuance of £76m covering roughly half the outlay. Goodwill rose £83m and intangibles £98m over the same FY2021–FY2022 interval, together representing over 40% of the prior-year asset base, while revenue grew £44m alongside a 45% step-up in goodwill, leaving the organic contribution to that growth unresolved.

What followed is harder to read in isolation. By the third post-acquisition year, goodwill had fallen £220m — an 82.7% reduction — and acquired intangibles declined £115m, a 97.0% fall, producing a combined £335m contraction in the acquired asset base. Whether that reflects impairment, disposal, or amortisation running its course is not determinable from the structural signals alone.

Running alongside this, exceptional items appeared in four of the five years spanning FY2021–FY2025. The persistence of that classification across the period raises the question of whether the costs being excluded from adjusted results represent a genuinely bounded integration burden or a more durable feature of the group's cost structure.

▶

Evidence

▶

Competing interpretations

Diligence question

What is the composition of the £335m reduction in goodwill and acquired intangibles between FY2022 and FY2025 — specifically, what amounts are attributable to scheduled amortisation, disposal proceeds, and any impairment charges — and, for the FY2022 investing outflow of £153m, what was the nature of the underlying transaction (business combination, asset purchase, or other investment), including the purchase price allocation and the carrying value of tangible net assets acquired?

Tension 2 of 6

Across FY2021–FY2025, reported net income rose from 10.0 to 17.0 while OCF moved in the opposite direction, falling from 39.0 to 34.0 — a divergence that sits uneasily alongside a period in which the company simultaneously reported profit growth. The OCF/NI ratio compressed sharply from 3.90× to 2.39× between FY2021 and FY2022, and FCF declined for three consecutive years through FY2024, with OCF itself swinging 52.7% peak-to-trough over the full five-year window.

Layered on top of this cash-earnings gap is a persistent normalisation adjustment: exceptional items appeared in four of five years, and the reported-versus-normalised margin gap reached 7.0% of revenue in FY2021 and 11.3% in FY2025, with the intervening years also registering gaps. The note context identifies a multi-year fundamental reorganisation programme as one source of these items.

What remains unresolved is whether the widening normalisation gap in FY2025 and the sustained OCF-to-income divergence reflect transient restructuring drag, a shift in the underlying cash-generative capacity of the business, or some combination — and whether the adjusted earnings figures that exclude recurring exceptional items present a materially different picture of economic performance than GAAP results.

▶

Evidence

▶

Competing interpretations

Diligence question

What were the individual components driving the compression in the OCF/NI ratio from 3.90× to 2.39× between FY2021 and FY2022 — specifically, what were the respective contributions of working capital movements, depreciation and amortisation step-changes, non-cash income items, and any impairment charges — and, given that the reported-versus-normalised margin gap widened further to 11.3% of revenue in FY2025, does management expect the exceptional items underpinning that gap to taper as the reorganisation programme concludes, or are any of these charges expected to recur beyond the programme's stated timeline?

Tension 3 of 6

Operating cash flow and net income have moved in opposite directions over the FY2021–FY2025 period: OCF fell from £39m to £34m while net income rose from £10m to £17m. The divergence has a working capital dimension — a £23m working capital outflow in FY2024 represented 6.7% of revenue, above the 5% threshold that typically signals structural absorption rather than timing.

The receivables position sharpened the picture further. DSO extended 17 days year-on-year, from 44 to 61 days between FY2024 and FY2025, a move large enough to materially affect cash timing regardless of its origin. Simultaneously, trade payables contracted from £9m to £5m across FY2022–FY2024, compressing the payables buffer at the same time receivables were lengthening.

What remains unresolved is whether the DSO deterioration reflects a change in customer payment behaviour, deliberate credit extension to support volumes, or a shift in the mix of counterparties — and whether the payables contraction is a negotiated outcome or a loss of supplier leverage.

The combination of these movements warrants scrutiny of whether cash generation can recover without a reversal in receivables terms.

▶

Evidence

▶

Competing interpretations

Diligence question

What is the composition of the trade receivables balance underlying the FY2025 DSO of 61 days — specifically, what proportion relates to customers with contractual payment terms exceeding 44 days versus balances that are overdue relative to existing terms, and how does the period-end concentration of revenue (i.e. the share of FY2025 annual revenue invoiced in the final weeks of the year) compare with the equivalent figure for FY2024?

Tension 4 of 6

Between FY2021 and FY2023, total debt grew 132.4% while cash fell 37.6% year-on-year, compressing the current ratio from 1.89× to 0.90× over two consecutive years. Interest expense then grew 67.6% from FY2022 to FY2023, and by FY2023 interest coverage had fallen to 0.37× — well below the 1.5× floor — before deteriorating further to -7.4× by FY2024. Net debt to EBITDA stood at 6.7× at FY2023.

Against this backdrop, the group paid £15m in dividends in FY2023 while carrying net debt of £80m under conditions flagged as elevated leverage and thin coverage. What remains unresolved is whether the operating income trajectory can stabilise coverage ratios before the debt structure becomes self-reinforcing, and whether the dividend policy reflects a deliberate capital allocation judgement or a constraint not yet revisited in light of the deterioration across all three coverage and liquidity measures simultaneously.

▶

Evidence

▶

Competing interpretations

Diligence question

With interest coverage falling from 10.6× in FY2022 to 0.37× in FY2023 — a period in which interest expense alone grew 67.6% — what was the relative contribution of the operating income decline versus the increase in interest costs to that compression, and does the group's current debt facility include variable-rate or repricing provisions that would cause interest expense to increase further if base rates remain elevated?

Tension 5 of 6

The aggregate claim on operating cash flow from dividends, net equity outflows, and net debt repayment reached 183% of OCF in FY2024 and widened to 266% in FY2025 — meaning distributions and financing obligations collectively consumed more than twice the cash the business generated from operations in the most recent year. That ratio is notable in isolation; it becomes harder to read alongside the trajectory of the underlying balance sheet, where net debt to EBITDA stood at 6.7× as recently as FY2023 and dividends of £15m were paid that year against a net debt position of £80m under conditions of elevated leverage and thin coverage.

Equity flows add a further layer of ambiguity. After net equity inflows of £73m in FY2021, the direction reversed, with net outflows of £6m recorded in both FY2024 and FY2025. In FY2024, those outflows — classified as buybacks of £6m — occurred in a year when GAAP net income was negative £33m.

What remains unresolved is whether the current capital allocation framework reflects a deliberate sequencing of priorities or an accumulation of commitments that has outpaced the cash generation available to service them, and whether the FY2025 OCF coverage ratio represents a temporary or durable condition.

▶

Evidence

▶

Competing interpretations

Diligence question

Given that concurrent capital allocation claims — dividends, net equity outflows, and net debt repayment — collectively consumed 266% of operating cash flow in FY2025, what is management's stated framework for sequencing or scaling these commitments, and what specific OCF trajectory or net debt milestone would trigger a reduction in distributions or buybacks?

Tension 6 of 6

NCC Group's cost structure has shifted materially over the four-year period to FY2025. SG&A as a proportion of revenue has risen from 22.5% to 34.3% — a 1,180 basis point expansion — reaching its highest point in the series. Simultaneously, gross margin has moved in the opposite direction, falling from 41.0% to 36.8% over the same period.

The combination is analytically notable because margin erosion is visible at two distinct levels of the income statement. A gross margin decline of this magnitude leaves less headroom to absorb overhead, while an SG&A ratio at a series high compounds that pressure at the operating level. What remains unresolved is whether the SG&A expansion reflects deliberate investment in growth capacity, a revenue base that has not scaled as expected, or cost growth that has outpaced the business's ability to control it — and whether the two segments, Cyber Security and Escode, are contributing to these dynamics differently.

▶

Evidence

▶

Competing interpretations

Diligence question

What is the composition of NCC Group's cost of sales in FY2025 — broken down by direct labour, subcontractor/third-party costs, and other direct costs — and how has each component's absolute value and share of revenue changed relative to FY2021, when gross margin stood at 41.0%? Specifically, can management indicate the extent to which the 4.2 percentage-point gross margin decline reflects changes in delivery mix (e.g. Cyber Security versus Escode revenue weighting), input cost inflation, pricing adjustments, or volume deleverage across the period?

Metric	2021	2022	2023	2024	2025	Direction
Revenue (GBPm)	271	315	335	342	239	↓ trend
Gross profit (GBPm)	111	133	132	118	88	↓ trend
Operating income (GBPm)	17	35	2	-57	-6	↓ trend
EBITDA (GBPm)	27	44	12	-43	4	↓ trend
Net income (reported) (GBPm)	10	23	-5	-33	17	↑ trend
Gross margin (%)	41.0	42.2	39.4	34.5	36.8	↓ trend
Operating margin (%)	6.3	11.1	0.6	-16.7	-2.5	↓ trend
Net margin (reported) (%)	3.7	7.3	-1.4	-9.7	7.1	↑ trend
Net margin (normalised) (%)	10.7	8.2	3.9	-11.7	-4.2	↓ trend
Reported vs normalised (%)	-7.0	-0.9	-5.2	2.1	11.3	↑ trend
SG&A as % revenue (%)	22.5	24.4	27.5	32.8	34.3	↑ trend
Capex as % revenue (%)	1.8	2.6	2.2	2.6	2.1	flat
OCF (GBPm)	39	55	32	26	34	↓ trend
FCF (GBPm)	34	47	25	17	29	↓ trend
Capex (GBPm)	5	8	7	9	5	↑ trend
Dividends paid (GBPm)	13	14	15	15	19	↑ trend
Net cash / (debt) (GBPm)	49	-85	-80	-73	-10	↓ trend
Total debt (GBPm)	68	158	114	103	23	↓ trend
Current ratio (×)	1.9×	1.1×	0.9×	1.2×	2.4×	↑ trend
Interest coverage (×)	7.4×	10.6×	0.4×	-7.4×	-1.4×	↓ trend
Return on equity (%)	—	8.2	-1.6	-13.7	8.2	flat
Goodwill as % assets (%)	42.4	46.2	51.1	37.4	13.4	↓ trend
Intangibles as % assets (%)	4.9	20.7	22.2	21.2	1.1	↓ trend
DSO (d)	88d	79d	58d	44d	61d	↓ trend

S2_001	▶ gross margin compression Gross margin deteriorated from 41.0% in FY2021 to 36.8% in FY2025, a decline of 420 basis points over the period. The financial statements do not disaggregate the components of cost of goods sold, leaving the mechanism of compression unresolved — the deterioration could reflect input cost pressures, labour cost increases, overhead absorption changes, shifts in product or geographic mix, pricing concessions, or the integration of lower-margin acquired revenues.
Why it matters If input cost or labour pressures are the primary driver, margin recovery would depend on pricing actions or operational efficiency gains. If the compression reflects mix shift or acquired revenues, the blended margin may stabilise at a lower equilibrium without operational intervention. Without visibility into the composition of COGS, the sustainability of the current margin level and the trajectory of future margins remain contingent on the underlying mechanism. Why this is open All candidate mechanisms are unaddressed; notes do not disaggregate COGS by input cost, labour, overhead, or service-level margin. The accounting boundary explicitly states that without disaggregated composition, the mechanism cannot be attributed. No supported candidates exist to anchor a finding. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes do not disclose raw material, labour, or supply chain cost pressures, nor do they disaggregate COGS by input cost, labour, overhead, or other component. The notes provide total COGS by segment but do not explain the drivers of COGS growth relative to revenue. The accounting boundary explicitly states that when gross margin composition is not disaggregated, the mechanism cannot be attributed. unaddressed While the notes disclose revenue by service type within Cyber Security (TAS £141.4m → £88.4m, C&I £55.2m → £48.5m, MS £91.8m → £76.4m, DFIR £20.6m → £13.1m, Other £33.1m → £12.5m), they do not disclose the gross margin of each service type. Without service-level margin data, the margin impact of the observed mix shift cannot be confirmed or corroborated. The notes do not address whether individual service margins changed or remained constant. unaddressed Cyber Security revenue declined materially from £342.1m (FY2024) to £238.9m (FY2025). However, the notes do not discuss fixed-cost absorption, overhead allocation, or the relationship between volume decline and gross margin. The notes do not explain whether the revenue decline reflects volume contraction, strategic exit, or other factors, nor do they address the mechanism of fixed-cost absorption in COGS. unaddressed The notes do not disclose pricing concessions, competitive pressure, or changes in revenue per unit. No note paragraph addresses pricing strategy, customer discounting, or competitive dynamics. unaddressed The notes do not identify any acquisitions completed in FY2025 or FY2024, nor do they disclose acquired revenue or the gross margin contribution of acquired businesses. No note paragraph addresses acquisition activity or acquired revenue margins.
S2_002	▶ reported vs normalised gap The reported-to-normalised earnings gap reached 11.3% of revenue in FY2025, with material gaps also recorded in FY2021 (7.0%), FY2023 (5.2%), and FY2024 (2.1%). The excluded items are confirmed as legitimate one-off charges — restructuring costs (£3.9m in FY2025, £9.4m in FY2024), goodwill impairment (£31.9m in FY2024), and strategic review costs (£3.8m Escode, £1.8m Cyber in FY2025) — explicitly identified by management and auditors as sufficiently unusual in nature or scale to warrant exclusion. However, the restructuring programme is corroborated as genuinely recurring across multiple reporting periods, with costs expected to continue into FY26, indicating that while individual charges are one-off in character, the underlying programme spans multiple years.
Why it matters The magnitude of the FY2025 gap reflects the concentration of restructuring and strategic review activity in that year rather than a systematic pattern of reclassifying operational costs. The confirmed one-off nature of the excluded items supports the use of normalised earnings as a comparator for underlying performance, provided that the multi-year restructuring programme is understood as a discrete initiative rather than a baseline operational feature. Confirmed, corroborated and unaddressed hypotheses confirmed The note explicitly identifies and quantifies restructuring costs (£3.9m in FY2025, £9.4m in FY2024), goodwill impairment (£31.9m in FY2024), and strategic review costs (£3.8m Escode, £1.8m Cyber in FY2025) as items excluded from adjusted results because they are "sufficiently unusual in terms of nature or scale." The note names the mechanisms (reorganisation, impairment, strategic review) and provides specific figures at the analytical level of the finding. The note confirms these items are separately identified and excluded from normalised earnings. “Each of these is considered by the Directors to be sufficiently unusual in terms of nature or scale so as not to form part of the underlying performance of the business.” Individually Significant Items (ISIs), 2024–2025 Annual Reports. confirmed The note explicitly names and quantifies acquisition-related transaction costs (Fox Crypto: £1.6m in FY2024) as an ISI excluded from adjusted results. The note also references disposal gains on DetACT/DDI (profit of £1.6m in FY2024, reclassified as ISI). These acquisition and disposal-related charges are explicitly identified and quantified in the ISI disclosure. “Transaction costs of Fox Crypto: 2024 £1.6m” Individually Significant Items (ISIs), 2024–2025 Annual Reports. corroborated The note discloses that fundamental reorganisation costs span multiple reporting periods (phases 1–3, March 2023 to December 2025) and that costs will continue into FY26, indicating the programme is not strictly one-off. Escode strategic review costs recurred in FY2025 (£3.8m vs £0.1m in FY2024), and Cyber review costs are new in FY2025 (£1.8m). The note references the multi-period nature of these costs but does not explicitly characterise them as recurring operational expenses. The mechanism is implied (costs spanning multiple periods) but not explicitly named as "recurring operational costs" — the note frames them as part of a defined restructuring programme or strategic review process. “It is expected that costs will continue to be incurred into FY26.” Individually Significant Items (ISIs), 2024–2025 Annual Reports. unaddressed The note does not address stock-based compensation, share-based payments, or any non-cash equity-based costs. There is no reference to employee share schemes, restricted stock units, or share options in the ISI disclosure or elsewhere in the supplied note paragraphs. The mechanism is not mentioned.
S2_003	▶ recurring exceptional items Exceptional items appear in 4 of 5 years over FY2021–FY2025. The recurrence is confirmed as reflecting a genuinely recurring transformation programme — a multi-phase restructuring initiative explicitly described as spanning multiple reporting periods with annual charges (FY2025 £3.9m, FY2024 £9.4m) and expected continuation into FY26. Management classification choices are corroborated as a mechanism — the notes acknowledge that judgement is exercised in assessing whether restructuring items qualify as exceptional — but the notes do not evidence that operationally routine costs are being systematically relabelled as exceptional; rather, the restructuring programme is explicitly framed as a defined multi-year initiative with genuine restructuring activity.
Why it matters The recurrence of exceptional items reflects the multi-year character of a specific transformation programme rather than a pattern of reclassifying routine operational costs. The distinction is material: if the restructuring programme concludes as planned, exceptional items should decline in subsequent periods, whereas systematic reclassification would perpetuate the pattern. The disclosed expectation of continued costs into FY26 provides a testable boundary for assessing whether the programme is genuinely time-bound. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly name a multi-phase restructuring programme spanning multiple reporting periods with costs disclosed in consecutive years (FY2025 £3.9m, FY2024 £9.4m). The notes further state "It is expected that costs will continue to be incurred into FY26," confirming the programme's multi-year character. This directly addresses the mechanism of a genuinely recurring transformation programme at the analytical level of the finding. “This reshaping is considered a fundamental reorganisation and restructuring programme that will span reporting periods, and the total project size and nature are considered in totality.” Individually Significant Items (ISIs), 2024–2025 Annual Reports. corroborated Notes acknowledge that management exercises judgement in classifying items as ISIs, referencing the classification mechanism. However, the notes do not evidence that operationally routine costs are being systematically relabelled as exceptional. The reorganisation programme is explicitly described as a multi-year programme with genuine restructuring activity, not as routine operational costs reclassified. The corroboration is partial: the notes confirm that classification discretion exists but do not support the specific claim that ongoing operational costs are being removed from normalised earnings annually through classification choice. “The Group will need to exercise judgement in assessing whether restructuring items should be classified as ISIs.” Individually Significant Items (ISIs), 2024–2025 Annual Reports. unaddressed The notes disclose strategic reviews of the Escode and Cyber businesses (professional fees of £3.8m and £1.8m respectively in FY2025) but do not reference acquisition integration as a source of recurring exceptional items. The strategic reviews are distinct from acquisition integration costs. No acquisition-related integration charges are identified in the note. The mechanism of serial acquisition integration is not addressed. unaddressed The notes list distinct items (reorganisation programme, Escode strategic review, Cyber review, disposals, impairments) but do not claim they are unrelated or will not recur together. The reorganisation programme is explicitly expected to continue into FY26, contradicting the "independent non-recurring events" framing for at least that component. The notes do not address whether the items will recur in future periods or whether their appearance in consecutive years reflects coincidence or underlying programme structure. The mechanism is not addressed.
S2_004	▶ sga ratio expansion SG&A as a percentage of revenue expanded 1,180 basis points from 22.5% in FY2021 to 34.3% in FY2025, reaching a series high. The expansion is corroborated as reflecting a denominator effect — continuing operations revenue declined sharply from £342.1m in FY2024 to £238.9m in FY2025, while administrative expenses declined from £151.1m to £81.3m. Additionally, £6.8m of head office overheads from discontinued operations were reallocated to continuing operations in FY2025, mechanically increasing the reported SG&A ratio independent of operational cost changes.
Why it matters The ratio expansion does not indicate deterioration in operational cost control; rather, it reflects the combined effect of revenue contraction and the reallocation of corporate overhead. Assessing the sustainability of the SG&A ratio requires evaluation of whether absolute SG&A costs will decline further as the business stabilises, and whether the reallocation of discontinued-operation overhead is temporary or structural to the continuing operations base. Confirmed, corroborated and unaddressed hypotheses corroborated The notes disclose that continuing operations revenue declined from £342.1m (FY2024) to £238.9m (FY2025), and that total administrative expenses declined from £151.1m to £81.3m. This is consistent with a denominator effect — revenue fell more sharply in absolute terms than SG&A, causing the ratio to expand. The notes provide the underlying facts (revenue decline and SG&A decline) that support the denominator effect mechanism, though they do not explicitly name the denominator effect as the explanation for the ratio expansion. Additionally, the notes disclose that £6.8m of head office overheads from discontinued operations were reallocated to continuing operations in FY2025, which mechanically increases the reported SG&A ratio of continuing operations independent of operational cost changes. “Revenue: Continuing operations 238.9, Continuing operations 342.1.” Segmental information, 2024–2025 Annual Reports. unaddressed The notes do not reference any deliberate investment strategy, capacity building, distribution expansion, marketing investment, or headcount scaling in anticipation of future revenue. The absolute SG&A declined from £151.1m (FY2024) to £81.3m (FY2025), which is inconsistent with an investment cycle. The notes provide segmental data but do not address the investment-ahead-of-revenue mechanism. unaddressed The notes do not reference administrative or selling cost growth, cost base compounding, or loss of operating leverage. The absolute total administrative expenses declined from £151.1m (FY2024) to £81.3m (FY2025), which is inconsistent with structural overhead creep. The notes do not explicitly state that overhead creep did not occur, but the disclosed absolute decline in SG&A weakens the mechanism substantially. The notes do not address this mechanism at the analytical level of the finding. unaddressed The notes do not reference any acquisitions, acquired entities, management layer duplication, integration teams, or integration synergies. The segmental disclosures do not address acquisition integration overhead as a driver of the SG&A ratio expansion. No mechanism is disclosed.

S3_001	▶ cash conversion divergence The divergence between operating cash flow and net income over FY2021–FY2025 is explained by material non-cash gains included in reported profit. Explicit disclosures identify gains on business disposal (£11.3m in FY2025, £1.6m in FY2024) and lease disposal (£1.9m in FY2025) that inflate reported net income without corresponding operating cash receipts. The FY2025 disposal gain of £11.3m is material relative to the reported profit of £17.1m and accounts for a substantial portion of the OCF/NI gap.
Why it matters The OCF/NI divergence reflects legitimate non-cash items rather than earnings quality deterioration. Adjusting for these disclosed gains would narrow the gap and align the cash and earnings signals more closely, indicating that underlying operating performance is not masked by accrual distortions. Confirmed, corroborated and unaddressed hypotheses confirmed The notes explicitly disclose non-cash gains on business disposal: FY2025 £(11.3)m and FY2024 £(1.6)m. These gains inflate reported NI (reducing the loss or increasing the profit) without corresponding cash receipt from operations. The FY2025 gain of £(11.3)m is material relative to the reported profit of £17.1m and contributes to the OCF/NI divergence. The notes also disclose gain on lease disposal £(1.9)m in FY2025. These non-cash gains are explicitly named and quantified in the cash flow reconciliation. “Profit on disposal of businesses: Year ended 30 September 2025 £(11.3)m, 16 month period ended 30 September 2024 £(1.6)m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed The notes explicitly disclose working capital movements for FY2025: receivables increase £(5.4)m, payables increase £10.3m, contract liabilities decrease £(1.1)m, and provisions decrease £(3.0)m. The net working capital movement is positive (payables increase exceeds receivables increase), which would support OCF rather than drag it. However, the finding references a multi-year divergence (FY2021–FY2025), and the supplied notes do not provide FY2021 data. Within FY2025 alone, working capital does not explain OCF/NI divergence. The notes do not address whether working capital build in prior years (FY2021–FY2024) is the driver of the endpoint divergence. unaddressed The notes disclose capitalised software and development expenditure: FY2025 £(0.4)m, FY2024 £(2.6)m. The amounts are small and declining, not increasing. The notes also disclose amortisation of software and development costs: FY2025 £2.1m, FY2024 £3.3m, which is a non-cash add-back in the OCF reconciliation. The notes do not evidence a material increase in the proportion of expenditure capitalised or a policy change that would explain the OCF/NI divergence. The capitalised amounts are immaterial relative to the gap. unaddressed The notes do not disclose any large receivable expected in the near term, any forward-looking statement about OCF/NI normalisation, or any specific timing issue that would explain the divergence as temporary. The notes provide the FY2025 and FY2024 reconciliation but do not address whether the divergence is expected to reverse in the following period.
S3_002	▶ dso elevated or deteriorating Days sales outstanding deteriorated 17 days year-over-year (44 to 61 days in FY2024–FY2025), but the mechanism driving this increase remains unresolved. The deterioration could reflect slower cash collection from customers, a shift in revenue timing toward the end of the period, a change in customer mix toward longer contractual payment terms, or structural industry norms for the sector. Without an accounts receivable ageing schedule or customer payment data, the specific driver cannot be identified.
Why it matters The DSO increase warrants monitoring, but its significance depends on the underlying cause. If driven by customer payment behaviour or credit terms extension, it may signal working capital pressure; if driven by revenue timing or customer mix, it may be a non-recurring or structural characteristic requiring no operational response. Why this is open All four candidate mechanisms are unaddressed despite notes being available (NV10 validation warning). The ageing schedule shows past-due receivables decreased and expected credit losses halved, which is inconsistent with collection efficiency deterioration, but the notes do not explicitly address collection behaviour, revenue timing concentration, customer mix shifts, or sector-specific payment cycles. The 17-day DSO deterioration (44→61 days) cannot be ranked against competing mechanisms. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes provide an ageing schedule showing past-due receivables decreased from £2.3m (>90 days, 2024) to £1.3m (>90 days, 2025), and expected credit losses halved from £(1.6)m to £(0.7)m. However, the notes do not explicitly address collection efficiency, payment behaviour, or whether invoices are outstanding longer before cash is received. The ageing data suggests collection may have improved, but the notes do not directly name or reference collection efficiency deterioration as a mechanism. The standard credit terms remain 30–60 days with no disclosure of term extensions or payment delays. Collection efficiency deterioration is not explicitly addressed in the notes. unaddressed The notes do not disclose revenue figures, quarterly revenue breakdown, or revenue timing within the year. DSO is mechanically sensitive to period-end revenue concentration, but without revenue data, the notes cannot confirm or corroborate whether high Q4 or H2 weighting occurred. The notes provide receivables and ageing data but no revenue context necessary to assess whether revenue concentration at period end explains the DSO increase. unaddressed The notes state "The standard period for credit sales varies from 30 days to 60 days" but do not disclose whether the customer mix has shifted toward longer-term customers (enterprise, public-sector), whether contractual payment terms have been extended, or whether the proportion of customers on net-60 or net-90 terms has increased. The notes reference standard terms but do not address customer mix changes or structural term lengthening. unaddressed The notes do not characterise the sector, state that long payment cycles are normal for the industry, or position the 61-day DSO as a structural or typical characteristic. No industry benchmark or sector-specific payment cycle disclosure is provided. The notes do not address whether elevated DSO represents deterioration or is a normal structural feature of the business sector.
S3_003	▶ working capital drag Working capital absorbed £23m (6.7% of revenue) in FY2024, but the composition of this outflow—whether driven by receivables build, inventory accumulation, payables reduction, or seasonal timing—is not specified in the available data. The net working capital movement does not distinguish among these drivers, each of which has different implications for cash conversion quality.
Why it matters The magnitude of working capital drag in FY2024 is material and warrants understanding its composition. If driven by revenue growth or supply chain pre-positioning, the outflow may be temporary and expected to reverse; if driven by payables compression or collection slowdown, it may signal structural cash conversion pressure. Why this is open All four candidate mechanisms are unaddressed despite notes being available (NV10 validation warning). The notes disclose working capital movements (receivables decrease £5.9m, payables decrease £11.9m, contract liabilities increase £5.5m) but provide no narrative explanation of revenue growth absorption, supply chain pre-positioning, supplier payment term changes, or seasonal timing effects. The £23m working capital outflow (6.7% of revenue) in FY2024 cannot be attributed to a specific mechanism. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes disclose working capital movements in the cash flow statement (receivables decrease of £(5.9)m, inventory decrease of £0.2m, payables decrease of £(11.9)m, contract liabilities increase of £5.5m, provisions increase of £0.7m) but provide no narrative explanation of revenue growth, business scaling, or the relationship between revenue expansion and working capital absorption. No figures on revenue growth or forward-looking demand are provided. The balance sheet shows trade and other receivables fell from £40.9m to £32.2m and contract assets rose from £17.2m to £20.1m, but the notes do not explain whether this reflects revenue growth driving receivables build or other factors. unaddressed The notes disclose inventory movements (decrease of £0.2m in the cash flow statement; balance sheet shows £0.8m at 31 May 2023 with no inventory balance disclosed at 30 September 2024, suggesting immaterial or nil holdings). However, the notes contain no reference to deliberate inventory pre-positioning, supply chain strategy, anticipated demand, or supply disruption concerns. No management commentary on inventory policy or strategic positioning is provided. unaddressed The notes disclose a decrease in trade and other payables of £(11.9)m in the cash flow statement, and the balance sheet shows payables rose from £44.7m to £46.8m (a £2.1m increase). However, the notes provide no narrative explanation of changes in supplier payment terms, early payment policies, or tightening of credit terms. No disclosure addresses whether payment terms were shortened, extended, or whether early payment discounts were taken. unaddressed The notes do not address seasonal patterns in working capital, expected release of working capital in the first half of the following year, or year-end timing effects. The cash flow statement itemises working capital movements at 30 September 2024 (the reporting date) but contains no commentary on whether these movements are expected to reverse or normalise in subsequent periods, or whether the year-end date captures an atypical working capital position.
S3_004	▶ cash flow bridge Operating cash flow improved from £26.4m in FY2024 to £33.5m in FY2025, contradicting any claim of deteriorating operating cash generation. The improvement was supported by favourable working capital movements, including a £5.4m decrease in receivables, a £10.3m increase in payables, and decreases in contract liabilities and provisions. The earlier observation of FCF decline over FY2022–FY2024 cannot be attributed to operating cash deterioration; the driver must be identified through the full cash bridge (investing and financing activities) rather than the operating layer alone.
Why it matters Operating cash generation strengthened in FY2025, indicating that any prior FCF weakness was driven by investment decisions or financing activities rather than deterioration in the core operating cash conversion process. This distinction is material for assessing the sustainability of cash generation. Why this is open Operating cash generation deterioration candidate is directly contradicted by disclosed figures: OCF improved from £26.4m (FY2024) to £33.5m (FY2025), with favourable working capital movements (payables increased £10.3m, receivables decreased £5.4m, provisions decreased £3.0m) offsetting a decline in cash inflow before working capital changes. The contradiction rules out the deterioration mechanism and supports the finding that FCF decline is not driven by operating weakness. The three-year FCF decline (FY2022–FY2024) is explained by the exclusion of the contradicted mechanism; the remaining unaddressed candidates (investment cycle, working capital build, structural FCF constraint) cannot be ranked without additional evidence. Confirmed, corroborated and unaddressed hypotheses contradicted OCF improved from £26.4m in 2024 to £33.5m in 2025, contradicting the claim that operating cash generation deteriorated. The notes show cash inflow before working capital changes declined from £48.5m to £38.7m, but this was offset by favourable working capital movements in 2025 (receivables decreased £(5.4)m, payables increased £10.3m, contract liabilities decreased £(1.1)m, provisions decreased £(3.0)m), resulting in net OCF improvement. Operating cash generation deterioration is directly contradicted by the disclosed figures. “Net cash generated from operating activities: Year ended 30 September 2025 £33.5m, 16 month period ended 30 September 2024 £26.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed The notes disclose CapEx of £(4.7)m for property, plant and equipment and £(0.4)m for software/development in 2025, totalling £(5.1)m, and £(6.2)m and £(2.6)m respectively in 2024, totalling £(8.8)m. CapEx declined in 2025, not elevated. Acquisition activity was £(1.0)m in 2024 and absent in 2025. The notes do not disclose an elevated investment phase, planned acquisition programme, or expected normalisation of CapEx. No mechanism linking investment cycle to FCF decline is evidenced. unaddressed The notes disclose working capital movements for 2025: trade and other receivables decreased £(5.4)m, contract assets decreased £0.4m, trade and other payables increased £10.3m, contract liabilities decreased £(1.1)m, and provisions decreased £(3.0)m. These movements were net favourable to cash flow in 2025, releasing cash rather than absorbing it. In 2024, receivables increased and payables decreased, which was less favourable. The notes do not disclose a working capital build in 2025 or identify working capital as a constraint on FCF. The mechanism of working capital build absorbing OCF is not evidenced for the 2025 period. unaddressed The notes provide a cash flow statement but do not include forward-looking commentary, management discussion of business model constraints, or statements about structural reinvestment requirements. No disclosure addresses whether the business model requires continuous high reinvestment relative to OCF or whether FCF is expected to remain thin as a structural feature. The mechanism is not addressed in the supplied note paragraphs.
S3_005	▶ payables compression Trade payables declined from £9m to £5m over FY2022–FY2024, but the mechanism—whether deliberate early payment, supplier term shortening, or reduced purchasing volume—cannot be determined from balance sheet data alone. Each mechanism produces the same payables outcome and has different implications for working capital management and supplier relationships.
Why it matters The payables compression is a material working capital movement that contributed to cash outflow, but its nature (strategic choice, structural procurement shift, or volume contraction) remains unresolved and would require procurement and supplier data to clarify. Why this is open All three candidate mechanisms are unaddressed. The notes disclose trade payables declined from £9m to £5m (FY2022–FY2024) but provide no narrative explanation of early payment policy, supplier mix shifts, or purchasing volume changes. The financial instruments note addresses debt facility management but does not reference early payment practices, procurement base composition, or purchasing activity. The payables compression cannot be attributed to a specific mechanism. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes contain no disclosure of early payment policy, settlement discounts, supplier relationship management initiatives, or strategic working capital decisions regarding payment timing. The financial instruments note addresses debt facility management and liquidity position but does not reference early payment practices or incentive programs that would explain deliberate acceleration of payables settlement. unaddressed The notes contain no disclosure of procurement base composition, supplier mix changes, product category shifts, geographic sourcing changes, or supplier type evolution. No information is provided on whether the supplier base has shifted toward vendors with structurally shorter payment terms, or whether procurement sourcing has changed in any material respect. unaddressed The notes contain no disclosure of purchasing volume, input cost trends, production activity, sales volume, or procurement spending levels. While the note discloses debt facility activity (drawdowns of £57.8m and repayments of £(75.0)m in 2024), this addresses external financing, not the purchasing activity or input cost base that would explain whether payables compression reflects volume contraction or stable terms with lower purchase volumes.
S3_006	▶ ocf fcf variability Operating cash flow exhibited substantial variability over FY2021–FY2025 (ranging 26.0–55.0, a 52.7% peak-to-trough swing), driven by lumpy working capital movements across multiple categories. Payables swung from a £11.9m outflow in FY2024 to a £10.3m inflow in FY2025; receivables and contract liabilities moved in opposite directions across the same periods. These non-monotonic swings across receivables, payables, and contract liabilities are consistent with timing-driven working capital volatility rather than deterioration in underlying earnings quality. A goodwill impairment of £31.9m in FY2024 (the trough year) signals acquisition-related stress, though the impairment itself is non-cash and does not directly explain the OCF trough; explicit quantification of acquisition-related cash costs is not disclosed.
Why it matters The OCF variability is primarily a working capital timing artefact expected to moderate over the medium term, rather than evidence of structural cash conversion deterioration. The FY2024 trough coincided with acquisition activity and goodwill impairment, suggesting that year was episodically stressed; the FY2025 recovery supports the view that the low point was transient rather than structural. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose material working capital swings in payables (£10.3m inflow in FY2025 vs. £(11.9)m outflow in FY2024), demonstrating a non-monotonic pattern consistent with lumpy working capital movements. Additional evidence: (Increase)/decrease in trade and other receivables shows FY2025 £(5.4)m outflow and (Decrease)/increase in contract liabilities shows FY2025 £(1.1)m outflow vs. FY2024 £5.5m inflow. These opposite-direction swings across multiple working capital categories confirm the mechanism at the analytical level of the finding. “Increase/(decrease) in trade and other payables: Year ended 30 September 2025 £10.3m, 16 month period ended 30 September 2024 £(11.9)m” Consolidated cash flow statement, 2024–2025 Annual Reports. corroborated Notes disclose a material goodwill impairment of £31.9m in the FY2024 period (the trough year in the observed window), signalling acquisition-related stress and integration challenges. However, the goodwill impairment is a non-cash charge (added back in the operating cash flow reconciliation) and does not directly reduce OCF. The notes also disclose "Acquisition of trade and assets as part of business combinations: 16 month period ended 30 September 2024 £(1.0)m", confirming acquisition activity, but do not quantify material transaction fees, integration cash costs, or acquired working capital absorption that would directly explain the OCF trough. The mechanism is referenced and partially evidenced but without explicit quantification of cash-based acquisition costs. “Impairment of goodwill: 16 month period ended 30 September 2024 £31.9m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed Notes disclose capex of £(4.7)m (FY2025) and £(6.2)m (FY2024) for property, plant and equipment, plus £(0.4)m (FY2025) and £(2.6)m (FY2024) for software and development. Total capex is modest relative to OCF (£5.1m and £8.8m respectively, representing 15% and 33% of OCF). The notes do not evidence a significant capex cycle or lumpy capital expenditure pattern that would explain the 52.7% peak-to-trough OCF swing observed across FY2021–FY2025. Capex timing is not addressed as a material driver of the variability signal.

S4_001	▶ debt liquidity movement The group's leverage profile shifted materially between FY2021 and FY2023 through three confirmed mechanisms: acquisition financing of £70m to fund the IPM Software Resilience business combination, refinancing of the revolving credit facility (£162.5m replacing £100m) and term loan in December 2022, and a step-change in interest expense from £3.7m to £6.2m driven by increased bank borrowing costs (£2.5m to £4.5m) and repricing of the new facility to 5.92% weighted average rate. Total debt grew 132.4% and net debt reached 6.7× EBITDA by FY2023, while interest coverage deteriorated to 0.37× as the finance cost denominator expanded.
Why it matters The leverage episode reflects a deliberate acquisition strategy funded through debt, followed by refinancing into a higher rate environment. The combination of acquisition debt, facility repricing, and elevated interest rates created a material step-change in finance costs that compressed interest coverage below typical covenant floors, signalling that the sustainability of the capital structure depends on the acquired EBITDA consolidating and deleveraging as planned. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly name the acquisition financing mechanism (IPM Software Resilience business acquisition) and quantify the facility amount ($70m Term Loan Facility). The mechanism is confirmed at the analytical level with a named acquisition and stated facility amount. “On 12 May 2021, the Group entered into a new Term Loan Facility Agreement. The facility made available under the Facility Agreement (the 'Term Facility') was a $70m amortising term loan facility, to fund the acquisition of the IPM Software Resilience business.” Cash and cash equivalents and borrowings; Financial instruments, 2022–2023 Annual Reports. confirmed Notes explicitly disclose refinancing activity: the new £162.5m RCF replaced the existing £100m RCF and the remaining $46.7m of the original $70m term loan. The notes further state "The new facility is considered an extinguishment of the previous RCF and Term Loan Facility Agreement." Financing cash flows in FY2023 show drawdown £70.8m and repayment £(115.6)m, consistent with refinancing. The mechanism is confirmed with named facilities and stated amounts. “In December 2022, the Group entered into a new four year £162.5m multi-currency revolving credit facility replacing our existing £100m multi-currency revolving credit facility and the remaining $46.7m of the original $70m term loan that was maturing in June 2024.” Cash and cash equivalents and borrowings; Financial instruments, 2022–2023 Annual Reports. unaddressed The notes do not disclose operating losses, working capital deterioration, capital expenditure pressures, or any operational cash shortfall that would necessitate debt drawdown to fund operations or investment. The cash decline from £73.2m to £34.1m is not attributed to operational shortfall in the notes. The mechanism is not addressed. unaddressed The notes do not disclose any shareholder distributions (dividends or buybacks) or capital return programmes funded by debt. No reference to capital returns or shareholder distributions appears in the supplied note paragraphs. The mechanism is not addressed. unaddressed The notes do not disclose EBITDA figures, EBITDA decline, or the composition of the net debt/EBITDA ratio movement. While the notes disclose that the leverage covenant was increased from 2.5x to 3.0x in December 2022 (suggesting anticipated higher leverage), they do not address whether the ratio movement was driven by denominator compression (EBITDA decline) or numerator increase (debt growth). The net debt/EBITDA ratio of 6.7× cited in the finding cannot be verified from the supplied notes. The mechanism is not addressed.
S4_002	▶ goodwill decline from peak Goodwill declined 83% from a peak of £266m at FY2022 to £46m by FY2025 through four confirmed mechanisms: an IAS 36 impairment charge of £31.9m in the period to 30 September 2024, business disposals totalling £5.9m in goodwill derecognition, foreign currency translation losses of £9.4m through OCI, and reclassification of £110.2m of goodwill to assets held-for-sale under IFRS 5 in the year ended 30 September 2025 as the Escode division was classified as a discontinued operation.
Why it matters The goodwill decline reflects both operational challenges (impairment and disposal of underperforming acquisitions) and balance sheet restructuring (IFRS 5 reclassification of a major division). The reclassification of Escode goodwill to held-for-sale in the final year accounts for the majority of the remaining decline and signals an active portfolio rationalization. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose an impairment charge on goodwill of £(31.9)m in the accumulated impairment section for the period to 30 September 2024. This is a direct income statement charge under IAS 36, naming the mechanism and providing the quantified figure at the analytical level of the finding. The impairment reduced goodwill carrying value by this amount. “Impairment: Goodwill £(31.9)m, Total £(31.9)m” Goodwill and intangible assets, 2024–2025 Annual Reports. confirmed Notes explicitly disclose goodwill disposals of £(5.9)m for the period to 30 September 2024, with reference to Note 31 for further detail. This confirms the derecognition of allocated goodwill on business disposal. Additionally, the notes state "the Fox Crypto CGU, which was disposed of during the year (with associated goodwill of £52.1m classified as held for sale as at 30 September 2024)" — confirming a major disposal mechanism, though the goodwill was reclassified to held-for-sale in 2024 rather than fully derecognised in 2025. “Disposals (see Note 31): Goodwill £(5.9)m, Software £(0.6)m, Development costs £(9.9)m, Intangibles sub-total £(10.5)m, Total £(16.4)m” Goodwill and intangible assets, 2024–2025 Annual Reports. confirmed Notes explicitly disclose FX translation losses on goodwill of £(9.4)m for the period to 30 September 2024, recorded through OCI as a movement in exchange rates. This confirms the mechanism of foreign currency weakening reducing goodwill on overseas operations. No FX movement on goodwill is disclosed for the year ended 30 September 2025. “Effects of movements in exchange rates: Goodwill £(9.4)m, Software £(0.2)m, Development costs £(0.1)m, Customer contracts and relationships £(9.4)m, Intangibles sub-total £(9.7)m, Total £(19.1)m” Goodwill and intangible assets, 2024–2025 Annual Reports. confirmed Notes explicitly disclose goodwill of £(110.2)m reclassified to assets held-for-sale in the year ended 30 September 2025. The notes further state "The Escode division, which was classified as a discontinued operation during the year, includes the following CGUs and associated allocated goodwill: Total Escode: Goodwill 2025 £110.2m" — confirming the reclassification of the entire Escode CGU including £110.2m of goodwill to held-for-sale under IFRS 5. This is the dominant mechanism explaining the £110.2m decline in gross goodwill in the final year, with no income statement charge (the reclassification is a balance sheet movement). “Assets classified as held for sale (Note 16): Goodwill £(110.2)m, Software £(3.8)m, Customer contracts and relationships £(95.1)m, Intangibles sub-total £(98.9)m, Total £(209.1)m” Goodwill and intangible assets, 2024–2025 Annual Reports.
S4_003	▶ cash flow bridge Operating cash flow improved from £26.4m in the 16-month period ended 30 September 2024 to £33.5m in the year ended 30 September 2025, contradicting a narrative of deteriorating operating cash generation; the improvement was driven by favourable working capital movements (receivables decreased £5.4m, payables increased £10.3m) that offset a decline in cash inflow before working capital changes from £48.5m to £38.7m.
Why it matters The three-year FCF decline cannot be attributed to operating cash generation deterioration in the most recent period; the cash bridge reveals that working capital management and financing flows, rather than operating performance, are the primary drivers of the reported FCF pattern. Why this is open FCF decline for 3 consecutive years (2022–2024) is a suspect tension with zero supported candidates. Investment cycle (Candidate 1) is unaddressed — CapEx declined in 2025, not elevated. Operating cash generation deterioration (Candidate 2) is contradicted — OCF improved from £26.4m to £33.5m in 2025. Working capital build (Candidate 3) is unaddressed — 2025 working capital movements were net favourable to cash flow. Structural FCF constraint (Candidate 4) is unaddressed — no forward-looking commentary or business model disclosure. The tension stands alone with no companion tension in the section that measures a related metric (e.g. OCF deterioration, CapEx surge) with supported evidence. No other tension in S4 addresses the cash flow bridge or FCF sustainability. The evidence cannot rank mechanisms — the finding itself (FCF decline) is observed, but the underlying drivers are either contradicted or unaddressed. Unresolved_only treatment is appropriate. Confirmed, corroborated and unaddressed hypotheses contradicted OCF improved from £26.4m in 2024 to £33.5m in 2025, contradicting the claim that operating cash generation deteriorated. The notes show cash inflow before working capital changes declined from £48.5m to £38.7m, but this was offset by favourable working capital movements in 2025 (receivables decreased £(5.4)m, payables increased £10.3m, contract liabilities decreased £(1.1)m, provisions decreased £(3.0)m), resulting in net OCF improvement. Operating cash generation deterioration is directly contradicted by the disclosed figures. “Net cash generated from operating activities: Year ended 30 September 2025 £33.5m, 16 month period ended 30 September 2024 £26.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed The notes disclose CapEx of £(4.7)m for property, plant and equipment and £(0.4)m for software/development in 2025, totalling £(5.1)m, and £(6.2)m and £(2.6)m respectively in 2024, totalling £(8.8)m. CapEx declined in 2025, not elevated. Acquisition activity was £(1.0)m in 2024 and absent in 2025. The notes do not disclose an elevated investment phase, planned acquisition programme, or expected normalisation of CapEx. No mechanism linking investment cycle to FCF decline is evidenced. unaddressed The notes disclose working capital movements for 2025: trade and other receivables decreased £(5.4)m, contract assets decreased £0.4m, trade and other payables increased £10.3m, contract liabilities decreased £(1.1)m, and provisions decreased £(3.0)m. These movements were net favourable to cash flow in 2025, releasing cash rather than absorbing it. In 2024, receivables increased and payables decreased, which was less favourable. The notes do not disclose a working capital build in 2025 or identify working capital as a constraint on FCF. The mechanism of working capital build absorbing OCF is not evidenced for the 2025 period. unaddressed The notes provide a cash flow statement but do not include forward-looking commentary, management discussion of business model constraints, or statements about structural reinvestment requirements. No disclosure addresses whether the business model requires continuous high reinvestment relative to OCF or whether FCF is expected to remain thin as a structural feature. The mechanism is not addressed in the supplied note paragraphs.
S4_004	▶ disposal driven deleveraging Net debt improved by £63m in FY2025 (from £-73m to £-10m), consistent with disposal proceeds of £61.4m and repayment of borrowings of £80.3m disclosed in the cash flow statement; the magnitude of proceeds is corroborated by the timing and scale of the net debt reduction, though the notes do not explicitly allocate proceeds across debt repayment and other capital allocation uses (equity dividends of £19.0m and treasury share acquisitions of £5.8m).
Why it matters The leverage improvement in FY2025 is a one-time event driven by business disposals rather than recurring operating cash generation; the sustainability of the improved leverage profile depends on whether the continuing business can sustain the OCF run-rate of £33.5m and whether pro-forma leverage (excluding disposed operations) differs materially from reported leverage. Confirmed, corroborated and unaddressed hypotheses corroborated Notes disclose disposal proceeds of £61.4m and net cash generated from operating activities of £33.5m. Notes also show repayment of borrowings of £(80.3)m. The figures are present and the magnitude of proceeds (£61.4m) is consistent with the finding that disposal proceeds were material to debt reduction, but the notes do not explicitly state that proceeds were applied to debt repayment or provide a cash bridge allocating the £61.4m to specific uses. The mechanism is implied by the co-occurrence of proceeds and repayment but not explicitly named or quantified as a causal relationship. Pro-forma continuing business OCF is not separately disclosed. “Sale proceeds of business disposals (net of cash disposed of): Year ended 30 September 2025 £61.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. corroborated Notes disclose disposal proceeds of £61.4m and show multiple capital allocation uses: repayment of borrowings of £(80.3)m, equity dividends paid of £(19.0)m, and acquisition of treasury shares of £(5.8)m. The notes evidence that proceeds were deployed across debt repayment and other capital allocation claims, but do not explicitly state the allocation of the £61.4m proceeds or prioritize debt repayment as the primary use. The mechanism is implied by the disclosure of proceeds and the various uses but not explicitly named or quantified as a proceeds allocation bridge. “Sale proceeds of business disposals (net of cash disposed of): Year ended 30 September 2025 £61.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed Notes disclose disposal of businesses with proceeds of £61.4m and profit on disposal of £(11.3)m, and show repayment of borrowings of £(80.3)m. However, the notes do not provide pro-forma earnings metrics, pro-forma leverage ratios, or any explicit analysis of how the disposal simultaneously reduced both debt and the earnings base. The notes do not address whether pro-forma leverage differs materially from reported leverage or quantify the earnings impact of the disposed entity. The mechanism is not named at the analytical level of the finding. unaddressed Notes disclose net cash generated from operating activities of £33.5m for the year ended 30 September 2025, but this figure includes both continuing and discontinued operations. The notes do not separately disclose continuing business OCF, nor do they state that continuing business OCF is sufficient to sustain the improved leverage position or maintain the new net debt level. The notes do not address the sustainability of the improved balance sheet position post-disposal. unaddressed Notes disclose profit on disposal of businesses of £(11.3)m and sale proceeds of £61.4m but provide no narrative on strategic rationale, business portfolio simplification, or change in business perimeter. The notes do not address whether the disposal signals a strategic shift or whether proceeds and leverage improvement are secondary to strategic objectives. The mechanism is not addressed in the financial statement notes.
S4_005	▶ interest coverage decline Interest coverage declined from 10.6× in FY2022 to -7.4× in FY2024 through a confirmed mechanism of refinancing at higher rates; despite total borrowings declining from £81.9m to £61.5m, interest on bank loans and overdrafts rose from £4.5m to £6.6m, reflecting a weighted average interest rate increase from 5.92% to 6.21% on the December 2022 refinanced facility. The mechanism of leverage accumulation outpacing earnings growth is contradicted by the disclosed debt reduction.
Why it matters The coverage deterioration reflects rate exposure rather than leverage trajectory; the business has deleveraged in absolute terms but faces higher financing costs in a higher rate environment, compressing coverage metrics independent of debt volume. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose refinancing in December 2022 into a new £162.5m facility and quantify the weighted average interest rate increase from 5.92% to 6.21%. Interest on bank loans and overdrafts rose from £4.5m to £6.6m despite drawn debt declining from £83.4m to £62.4m, confirming that higher rates (not higher leverage) drove the interest charge increase. The mechanism is confirmed: refinancing into a higher rate environment is explicitly named and quantified. “The weighted average interest rate is 6.21% for the period ended 30 September 2024 (2023: 5.92%).” Finance costs; Cash and cash equivalents and borrowings; Financial instruments, 2023–2024 Annual Reports. contradicted Notes disclose that borrowings declined from £81.9m to £61.5m, a reduction of £20.4m. This directly contradicts the mechanism's claim that "debt levels have grown faster than operating income." The notes show deleveraging, not leverage accumulation. Interest charges rose (£6.6m vs £4.5m on bank loans) despite lower debt levels, which is inconsistent with debt accumulation driving the coverage decline. The mechanism is ruled out by the disclosed debt trajectory. “Unamortised arrangement fees of £0.9m (2023: £1.5m) have been offset against the amounts drawn down, resulting in a carrying value of borrowings at 30 September 2024 of £61.5m (2023: £81.9m).” Finance costs; Cash and cash equivalents and borrowings; Financial instruments, 2023–2024 Annual Reports. unaddressed The notes do not address operating income, revenue trends, margin compression, or earnings deterioration. While the finding itself (negative coverage of -7.4026x) implies operating income has weakened or turned negative, the financial notes provided do not disclose operating income movements, revenue performance, or profitability trends. The mechanism remains unaddressed by the supplied disclosures.
S4_006	▶ current ratio decline The current ratio declined from 1.89× in FY2021 to 0.90× in FY2023 through genuine liquidity compression: trade receivables fell £13.9m (from £40.6m to £26.7m), contract assets fell £5.8m (from £23.0m to £17.2m), and cash fell £39.1m (from £73.2m to £34.1m). The mechanism of short-term debt accumulation is contradicted by total loans and borrowings declining from £125.6m to £81.9m.
Why it matters The current ratio approaching unity reflects a material reduction in the liquid asset base rather than a shift toward short-term funding; the business has less buffer against near-term cash calls and potential refinancing pressure, though the absolute debt level has declined. Confirmed, corroborated and unaddressed hypotheses corroborated Notes disclose material declines in liquid current assets: trade receivables fell from £40.6m to £26.7m (£13.9m reduction), contract assets fell from £23.0m to £17.2m (£5.8m reduction), and cash fell from £73.2m to £34.1m (£39.1m reduction). These disclosed movements in current assets are consistent with genuine liquidity compression. The current ratio fell to 0.9009x, approaching unity, which reflects reduced liquidity buffer. The notes do not explicitly name this as "liquidity compression" or reference "refinancing pressure," but the disclosed asset movements corroborate the mechanism of declining current assets creating tighter liquidity. “Trade receivables: Group 2023 £26.7m, Group 2022 £40.6m” Trade and other receivables; Financial instruments, 2022–2023 Annual Reports. contradicted Notes disclose that total loans and borrowings fell from £(125.6)m in 2022 to £(81.9)m in 2023, representing a material reduction. The mechanism of "short-term debt accumulation" is directly contradicted by this disclosure. While the revolving credit facility increased in drawdown, the bank term loan was fully repaid, resulting in net debt reduction. Short-term debt did not accumulate; total debt declined significantly. “Total loans and borrowings (excluding lease liabilities): Group 2023 £(81.9)m, Group 2022 £(125.6)m” Trade and other receivables; Financial instruments, 2022–2023 Annual Reports. unaddressed Notes disclose that trade receivables fell from £40.6m to £26.7m and contract assets fell from £23.0m to £17.2m, but do not explicitly attribute this reduction to operational efficiency, supply chain tightening, or a deliberate working capital optimisation programme. The notes show the outcome (lower receivables) but do not name the mechanism as optimisation. No disclosure of efficiency initiatives, working capital management policy, or supply chain restructuring is provided.

S5_001	▶ dividends despite cash or debt pressure Operating cash flow of £32.1m in FY2023 exceeded equity dividends paid of £14.5m, and free cash flow (operating cash flow less investing cash outflow of £6.3m) remained positive and materially above the dividend, directly contradicting the premise that cash generation was insufficient to cover distributions or that the dividend was funded from debt drawdown or asset disposals.
Why it matters The net debt position in FY2023 does not reflect a dividend-funding shortfall; rather, it reflects the company's broader capital allocation decisions, including the £70.8m borrowing drawdown, which was deployed across multiple uses independent of dividend coverage. Why this is open Tension is material to capital allocation character. Finding text asserts dividends maintained despite net debt and stress co-conditions (elevated leverage, thin coverage). Two candidates are contradicted (dividend funded from debt, FCF negative due to investment cycle), ruling out those mechanisms. Two candidates remain unaddressed (dividend as confidence signal, leverage due to acquisition with dividend sustainable). The contradicted candidates strengthen the supported mechanism: OCF was sufficient to fund the dividend without recourse to debt drawdown. The net debt position is real but does not establish unsustainability — the accounting boundary correctly notes that assessment requires FCF coverage, covenant headroom, and management guidance. The tension surfaces a capital allocation choice (maintaining distributions despite leverage) that is analytically distinct and material to section scope. Confirmed, corroborated and unaddressed hypotheses contradicted The notes disclose net cash generated from operating activities of £32.1m, which exceeds the equity dividends paid of £(14.5)m. This directly contradicts the premise that "cash generation [was] insufficient to cover the dividend." Operating cash flow alone was sufficient to fund the dividend without recourse to debt drawdown or asset disposals. While the company did drawdown borrowings of £70.8m in the period, this was not necessary to fund the dividend itself. “Net cash generated from operating activities: 2023 £32.1m” Consolidated cash flow statement, 2022–2023 Annual Reports. contradicted The notes disclose operating cash flow of £32.1m and investing cash outflow of £(6.3)m, yielding free cash flow that is positive and materially exceeds the dividend of £(14.5)m. The interpretation assumes FCF is negative due to investment cycle, but the disclosed figures show FCF is positive. Capital expenditure (property, plant and equipment £(3.9)m and software/development £(3.4)m) totals £(7.3)m, which is modest relative to operating cash generation. This directly contradicts the premise that "FCF [is] negative due to investment cycle." “Net cash generated from operating activities: 2023 £32.1m, Net cash used in investing activities: 2023 £(6.3)m” Consolidated cash flow statement, 2022–2023 Annual Reports. unaddressed The notes disclose that equity dividends paid were £(14.5)m in 2023, matching the prior year at £(14.4)m, but do not articulate management's rationale for maintaining the dividend or characterise it as a signal of confidence despite leverage or FCF pressure. The dividend amount is disclosed but not the strategic intent or reasoning behind the distribution policy decision. unaddressed The notes show acquisition expenditure of £(1.0)m in FY2023, compared to £(153.0)m in the prior year (2022). The major acquisition occurred in FY2022, not FY2023. The notes do not explain the current net debt position as a consequence of acquisition activity in FY2023, nor do they articulate management's expectation to delever from acquired EBITDA or state that the dividend policy is sustainable on that basis. The goodwill impairment of £12.8m in FY2023 suggests prior-year acquisition performance challenges, but the notes do not address the link between acquisition leverage and dividend policy.
S5_002	▶ equity flow reversal Net equity outflows of £6m in both FY2024 and FY2025 are confirmed to reflect a business maturity transition, with treasury share acquisitions of £5.8m disclosed in each year alongside dividends of £24.3m (FY2024) and £9.2m (FY2025), evidencing a shift from a growth-funding posture to a return-of-capital posture. Employee share scheme settlement is corroborated as a concurrent mechanism, with share option exercises disclosed in both years, though the quantified cash impact of scheme settlement is not separately itemized and does not account for the full £6m net outflow.
Why it matters The primary driver of sustained net equity outflows is a deliberate capital return policy consistent with business maturity and confidence in cash generation; employee share scheme mechanics contribute to the outflow but are secondary to the directed buyback programme. Confirmed, corroborated and unaddressed hypotheses confirmed Notes explicitly disclose "Acquisition of treasury shares" of £(5.8)m in both FY2024 and FY2025, naming the buyback mechanism at the analytical level of the finding. Combined with disclosed dividends of £(24.3)m (FY2024) and £(9.2)m (FY2025), the notes evidence a capital return posture consistent with business maturity. The treasury share acquisition is a quantified, named capital allocation decision disclosed in the statement of changes in equity. “Acquisition of treasury shares: Retained earnings £(5.8)m, Total £(5.8)m” Consolidated statement of changes in equity; Called up share capital and reserves, 2024–2025 Annual Reports. corroborated Notes disclose share option exercise in both years (481,449 shares in FY2025; 2,395,738 in FY2024), evidencing an employee share scheme mechanism. However, the quantified cash impact is minimal (£0.3m issuance proceeds in both years), and the notes do not separately disclose a cash outflow for scheme settlement or vesting. The mechanism is referenced but the scale and cash flow characterization do not align with the £6m net outflow finding. Share-based payments (£2.3m in FY2024, £2.1m in FY2025) are non-cash charges, not cash outflows. “During the year, 481,449 (2024: 2,395,738) new ordinary shares of 1p were issued as a result of the exercise of share options.” Consolidated statement of changes in equity; Called up share capital and reserves, 2024–2025 Annual Reports. unaddressed The notes do not disclose an Employee Benefit Trust or attribute treasury share acquisitions to an EBT. The only treasury share transaction disclosed is "Acquisition of treasury shares" of £(5.8)m in both years, but the notes do not specify whether these were acquired by an EBT or directly by the company. Without explicit reference to an EBT structure or EBT-driven purchases, this mechanism is not addressed in the supplied note paragraphs.
S5_003	▶ capital allocation competition Three concurrent capital allocation claims—dividends, net equity outflows, and net debt repayment—collectively consumed 183% of operating cash flow in FY2024 and 266% in FY2025, surfacing the breadth of simultaneous capital deployment without establishing whether any individual claim is at risk or whether the aggregate is unsustainable.
Why it matters The mechanism driving this configuration remains open: whether strong OCF generation supports all concurrent uses without incremental debt stress, whether the co-occurrence reflects opportunistic timing that will separate in subsequent periods, or whether distributable surplus is compressing and leaving limited buffer for OCF deterioration cannot be determined from the financial statements alone. Why this is open Tension is material to capital allocation character. Finding text documents three concurrent capital allocation claims (dividends, net equity outflows, net debt repayment) totalling 183% of OCF (FY2024) and 266% of OCF (FY2025). All three candidates are unaddressed. NV10_ALL_UNADDRESSED_WITH_NOTES is present, indicating that notes are available but do not address the candidates. The notes disclose the three concurrent claims and OCF figures, but do not characterize OCF as "strong," do not assert that competition is "managed," do not explain timing as opportunistic, and do not assess whether distributable surplus is compressing or buffer is adequate for OCF deterioration. The pattern is observational: concurrent claims exceed OCF in both years, requiring incremental debt funding (£21.1m FY2025, £57.8m FY2024). The evidence does not rank mechanisms — no candidate is supported by note disclosure. The tension stands alone with no companion tension identified. Treatment is unresolved_only because the evidence surfaces a capital allocation pattern (concurrent claims exceeding OCF) without confirming which mechanism explains the company's approach to managing the competition. Confirmed, corroborated and unaddressed hypotheses unaddressed The notes quantify OCF at £33.5m (FY2025) and £26.4m (FY2024), and disclose the three concurrent claims (dividends, treasury share acquisitions, and net debt repayment). However, the notes do not characterize OCF as "strong" relative to claims, do not assert that competition is "managed," and do not state that claims are supported "without incremental debt." The notes show net borrowing drawdowns of £21.1m (FY2025) and £57.8m (FY2024), which indicates that concurrent claims exceed OCF and require incremental debt funding. The notes do not address the interpretation's core assertion that strong OCF generation supports all concurrent uses. unaddressed The notes disclose the three concurrent claims in both FY2025 and FY2024 but provide no commentary on timing strategy, opportunism, or expectations for future periods. The notes do not state whether the co-occurrence of acquisitions, buybacks, and debt repayment is transient or sustained, nor do they explain the timing as opportunistic. The interpretation requires forward-looking or strategic commentary that the notes do not provide. unaddressed The notes disclose aggregate capital claims of £84.0m (FY2025) and £37.5m (FY2024) against OCF of £33.5m and £26.4m respectively, showing that concurrent claims exceed OCF in both years. The notes also show net borrowing drawdowns of £21.1m (FY2025) and £57.8m (FY2024), indicating that the company funded the gap between claims and OCF through incremental debt. However, the notes do not use the term "distributable surplus," do not assess whether surplus is "compressing," and do not comment on the adequacy of buffer for OCF deterioration. The pattern is consistent with the interpretation but the notes do not explicitly address the mechanism of compressing surplus or buffer erosion.
S5_004	▶ buyback without gaap profitability Material net equity outflows of £6m occurred in FY2024 despite negative GAAP net income of £33m, a configuration that does not establish whether the buyback was funded by positive operating cash flow (with non-cash charges such as share-based compensation and depreciation depressing GAAP income) or whether it reflects board confidence in earnings recovery or genuine operating deterioration.
Why it matters The sustainability and rationale for the capital return decision cannot be assessed without determining whether OCF generation remained positive and sufficient to cover the buyback, or whether the buyback was funded from balance sheet cash or incremental debt. Why this is open Tension is material to capital allocation character. Finding text documents material net equity outflows (£6m buyback) in FY2024 despite negative GAAP net income (£-33m). All three candidates are unaddressed. NV10_ALL_UNADDRESSED_WITH_NOTES is present, indicating that notes are available but do not address the candidates. Note 27 confirms the buyback via treasury share increase but provides no quantification of cash cost, no operating cash flow figures, no statement that the buyback was funded from OCF, no disclosure of management's earnings outlook or recovery expectations, and no disclosure of OCF trends, balance sheet cash position, or debt levels. The accounting boundary correctly notes that non-cash charges (SBC, D&A) are the most common explanation for this configuration in high-SBC businesses, but the notes do not provide the OCF generation, non-cash charge addbacks, or capital allocation rationale required to confirm that mechanism. The evidence does not rank mechanisms — no candidate is supported by note disclosure. The tension stands alone with no companion tension identified. Treatment is unresolved_only because the evidence surfaces a capital allocation choice (buyback at GAAP trough) without confirming which mechanism explains the company's decision. Confirmed, corroborated and unaddressed hypotheses unaddressed Note 27 discloses the increase in treasury shares (from 868,800 to 5,158,090), confirming a buyback occurred, but provides no quantification of cash cost, no operating cash flow figures, and no statement that the buyback was funded from OCF or that management assessed OCF coverage. The mechanism — that non-cash charges (SBC, D&A) depress GAAP income while OCF remains positive and funds the buyback — requires disclosure of OCF generation, non-cash charge addbacks, and the capital allocation rationale. None of these are addressed in the note. unaddressed Note 27 confirms the buyback via treasury share increase but provides no disclosure of management's earnings outlook, recovery expectations, or any statement that the buyback was undertaken as a contrarian signal of confidence in earnings normalisation. The mechanism — board confidence in medium-term earnings recovery — is not addressed. The note is silent on management's forward earnings view or the rationale for capital return at a GAAP trough. unaddressed Note 27 confirms the buyback via treasury share increase but provides no disclosure of operating cash flow trends, balance sheet cash position, debt levels, or any statement that the buyback was funded from balance sheet cash or incremental debt rather than OCF. The mechanism — that OCF is declining and the buyback is funded from non-operating sources — requires disclosure of cash flow generation, liquidity position, and financing sources. None of these are addressed in the note.
S5_005	▶ disposal driven deleveraging Net debt improved by £63m in FY2025 (from £73m to £10m), with disposal proceeds of £61.4m disclosed in the same period alongside operating cash flow of £33.5m and borrowing repayment of £80.3m; the magnitude of proceeds is consistent with the finding that disposal proceeds were material to debt reduction, though the notes do not explicitly allocate the proceeds to specific uses or provide a cash bridge confirming that proceeds were applied to debt repayment.
Why it matters The debt reduction is corroborated as a one-time event funded by asset disposals rather than recurring operating cash flow, and the pro-forma leverage of the continuing business may differ materially from reported leverage if the disposed entity generated material operating cash flow; the sustainability of the deleveraged position depends on the OCF generation capacity of the remaining business. Confirmed, corroborated and unaddressed hypotheses corroborated Notes disclose disposal proceeds of £61.4m and net cash generated from operating activities of £33.5m. Notes also show repayment of borrowings of £(80.3)m. The figures are present and the magnitude of proceeds (£61.4m) is consistent with the finding that disposal proceeds were material to debt reduction, but the notes do not explicitly state that proceeds were applied to debt repayment or provide a cash bridge allocating the £61.4m to specific uses. The mechanism is implied by the co-occurrence of proceeds and repayment but not explicitly named or quantified as a causal relationship. Pro-forma continuing business OCF is not separately disclosed. “Sale proceeds of business disposals (net of cash disposed of): Year ended 30 September 2025 £61.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. corroborated Notes disclose disposal proceeds of £61.4m and show multiple capital allocation uses: repayment of borrowings of £(80.3)m, equity dividends paid of £(19.0)m, and acquisition of treasury shares of £(5.8)m. The notes evidence that proceeds were deployed across debt repayment and other capital allocation claims, but do not explicitly state the allocation of the £61.4m proceeds or prioritize debt repayment as the primary use. The mechanism is implied by the disclosure of proceeds and the various uses but not explicitly named or quantified as a proceeds allocation bridge. “Sale proceeds of business disposals (net of cash disposed of): Year ended 30 September 2025 £61.4m” Consolidated cash flow statement, 2024–2025 Annual Reports. unaddressed Notes disclose disposal of businesses with proceeds of £61.4m and profit on disposal of £(11.3)m, and show repayment of borrowings of £(80.3)m. However, the notes do not provide pro-forma earnings metrics, pro-forma leverage ratios, or any explicit analysis of how the disposal simultaneously reduced both debt and the earnings base. The notes do not address whether pro-forma leverage differs materially from reported leverage or quantify the earnings impact of the disposed entity. The mechanism is not named at the analytical level of the finding. unaddressed Notes disclose net cash generated from operating activities of £33.5m for the year ended 30 September 2025, but this figure includes both continuing and discontinued operations. The notes do not separately disclose continuing business OCF, nor do they state that continuing business OCF is sufficient to sustain the improved leverage position or maintain the new net debt level. The notes do not address the sustainability of the improved balance sheet position post-disposal. unaddressed Notes disclose profit on disposal of businesses of £(11.3)m and sale proceeds of £61.4m but provide no narrative on strategic rationale, business portfolio simplification, or change in business perimeter. The notes do not address whether the disposal signals a strategic shift or whether proceeds and leverage improvement are secondary to strategic objectives. The mechanism is not addressed in the financial statement notes.
S5_006	▶ dividend per share movement Dividend per share increased from 0.05p in FY2024 to 0.06p in FY2025, a movement that does not establish whether the increase was supported by higher earnings per share or free cash flow per share, driven by a board policy of progressive distributions independent of earnings growth, influenced by a change in share count from buybacks or issuances, or reflects a one-time adjustment.
Why it matters The mechanism underlying the DPS increase and its consistency with underlying earnings or cash generation capacity remains unresolved and requires separate assessment of earnings trajectory, cash conversion, and dividend cover. Why this is open Tension is material to capital allocation character. Finding text documents DPS increase from 0.05 (FY2024) to 0.06 (FY2025). All four candidates are unaddressed. No note paragraphs were supplied for this tension, and the input explicitly states "Cannot assess" for each candidate due to absence of note disclosure. The accounting boundary correctly notes that a DPS movement does not establish whether the dividend is covered by earnings or FCF, nor whether the change reflects a policy decision or a one-time adjustment. Without note disclosure of EPS, FCF per share, earnings trajectory, dividend policy, dividend cover metrics, share count movements, or special dividend commentary, the evidence does not rank mechanisms. The tension stands alone with no companion tension identified. Treatment is unresolved_only because the evidence surfaces a DPS movement without confirming which mechanism explains the increase. Confirmed, corroborated and unaddressed hypotheses unaddressed No note paragraphs supplied. Cannot assess whether EPS, FCF per share, or earnings trajectory are disclosed, or whether management commentary addresses confidence in earnings growth as a driver of the DPS increase. unaddressed No note paragraphs supplied. Cannot assess whether dividend policy disclosures, progressive dividend commitments, or dividend cover metrics are disclosed. unaddressed No note paragraphs supplied. Cannot assess whether share count movements (buybacks, issuances, scrip dividend take-up) are disclosed or quantified. unaddressed No note paragraphs supplied. Cannot assess whether special dividends, catch-up adjustments, or period-length effects are disclosed.

Key Tensions & Management Questions

Key Metrics

Financial Analysis

Important Notice